TFF Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is May - April.

Millions EUR. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Cash & Equivalents	79.67	92.94	102.34	97.58	94.64
Cash & Short-Term Investments	79.67	92.94	102.34	97.58	94.64
Cash Growth	-14.29%	-9.18%	4.88%	3.10%	15.39%
Accounts Receivable	81.1	99.66	98.57	78.48	47.86
Other Receivables	26.83	17.01	16.49	7.28	12.35
Receivables	107.93	116.66	115.06	85.76	60.21
Inventory	451.59	417.13	345.94	277.15	256.6
Total Current Assets	639.19	626.74	563.34	460.49	411.46
Property, Plant & Equipment	209.19	202.02	151.86	140.16	125.2
Long-Term Investments	16.43	18.44	17.37	15.74	16.55
Goodwill	114.26	108.18	99.22	101.4	85.98
Other Intangible Assets	5.25	5.12	4.99	4.6	4.47
Long-Term Deferred Tax Assets	8.62	8.5	6.78	12.61	16.01
Other Long-Term Assets	1.45	-	-	-	-
Total Assets	995.14	968.99	843.55	735	659.67
Accounts Payable	28.64	40.6	46.32	25.94	18.71
Short-Term Debt	142.77	188.26	170.88	110.46	94.63
Current Portion of Long-Term Debt	103.35	57.26	69.59	44.87	58.85
Other Current Liabilities	35.78	43.61	36.63	36.73	18.81
Total Current Liabilities	310.53	329.74	323.42	218	191.01
Long-Term Debt	139.59	107.89	41.27	74.13	74.04
Long-Term Leases	7.98	6.12	4.77	4.97	5.13
Long-Term Deferred Tax Liabilities	15.69	11.65	9.08	8.89	12.64
Other Long-Term Liabilities	0.6	0.09	0.57	0.33	0.12
Total Liabilities	476.77	457.86	381.31	308.88	285.93
Common Stock	8.67	8.67	8.67	8.67	8.67
Retained Earnings	30.71	56.45	52.82	35.86	20.04
Comprehensive Income & Other	448.19	424.58	380.96	363.01	339.63
Total Common Equity	487.57	489.7	442.45	407.54	368.34
Minority Interest	30.8	21.42	19.78	18.58	5.4
Shareholders' Equity	518.37	511.12	462.24	426.12	373.74
Total Liabilities & Equity	995.14	968.99	843.55	735	659.67
Total Debt	393.69	359.53	286.5	234.44	232.65
Net Cash (Debt)	-314.02	-266.59	-184.16	-136.86	-138.01
Net Cash Per Share	-14.49	-12.30	-8.50	-6.31	-6.37
Filing Date Shares Outstanding	21.68	21.68	21.68	21.68	21.69
Total Common Shares Outstanding	21.68	21.68	21.68	21.68	21.69
Working Capital	328.66	297	239.93	242.49	220.45
Book Value Per Share	22.49	22.59	20.41	18.80	16.99
Tangible Book Value	368.07	376.4	338.25	301.55	277.89
Tangible Book Value Per Share	16.98	17.36	15.60	13.91	12.81
Land	23.47	22.9	20.83	19.29	16.19
Buildings	129.59	117.45	93.87	89.91	79.27
Construction In Progress	23.56	26.61	13.92	2.34	0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q